Reactions 1704, p271 - 2 Jun 2018 Oral mucositis and diarrhoea: 2 case reports In a prospective study of 10 patients, two patients [ages and sexes not stated] were described, out of whom one patient developed oral mucositis and the other patient developed diarrhoea during treatment with mycophenolate mofetil for graft versus host disease (GVHD) prophylaxis. The patients underwent allogeneic haematopoietic stem cell transplantation for haematologic malignancies following unspecified conditioning therapy. On day 0 of the transplantation, the patients started receiving treatment with IV mycophenolate mofetil 1000mg over 2 hours [frequency not clearly stated] and another drug for GVHD prophylaxis. On day 1 of the transplantation, the patients started receiving filgrastim. The patients received the IV mycophenolate mofetil therapy for 10 days. On day 11 of the GVHD prophylaxis treatment, the IV mycophenolate mofetil was switched to oral mycophenolate mofetil at the same dose of 1000mg. However, one patient developed grade III oral mucositis, while the other patient developed grade III diarrhoea during the mycophenolate mofetil treatment. Both the conditions were transient and resolved without discontinuation of mycophenolate mofetil therapy [times to reactions onsets not stated]. The patients were treated with mycophenolate mofetil for 30 days. Author comment: "Individual cases of transient and curable grade III oral mucositis and diarrhea were observed; however, [mycophenolate mofetil] was not discontinued." Kurata K, et al. Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients. Cancer Chemotherapy and Pharmacology 81: 839-846, No. 5, May 2018. Available from: URL: http://doi.org/10.1007/s00280-018-3550-7 - Japan 803322950 » Editorial comment: Details of this case report have previously been published [see Reactions 1702 p188; 803320494]. 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera